Evolving trends in cardiogenic shock management in acute myocardial infarction: mortality, discharge outcomes, and economic implications.

ABSTRACT: In-hospital mortality among patients with acute myocardial infarction (AMI)-related cardiogenic shock (CS) remains approximately 30-45%. While costly mechanical circulatory support (MCS) devices were expected to improve prognosis, previous studies have demonstrated limited benefits. This retrospective study aimed to evaluate contemporary mortality, discharge rates to home, and associated medical costs in patients with AMI-related CS, using the Japanese nationwide administrative dataset, JROAD-DPC, between 2012 and 2023. Of 75,619 patients with AMI-related CS, in-hospital mortality occurred in 33,869 (45%). Among 41,750 survivors, 9850 (24%) were not discharged home. Costs for all patients averaged 15,500 USD, with 26,300 USD for survivors treated with MCS, 13,600 USD for survivors without,

SUBMITTER: Higuchi S 

PROVIDER: S-EPMC12780162 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature